GenePeeks Appoints CMO
This article was originally published in Scrip
GenePeeks, a genetic information company, has named Jeffrey Field as chief commercial officer. Prior to joining GenePeeks, Field was vice-president of sales and client services at Foundation Medicine, where he had a role in developing and executing the launch plan for its genomic profiling services.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.